Clinical trial
Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative Treatment
NCT04264260 is registered in ClinicalTrials.gov with Kaohsiung Medical University Chung-Ho Memorial Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative Treatment
- Lead sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 24, 2019
- Completion date
- May 30, 2025
- Enrollment
- 42 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cholangiocarcinoma, intrahepatic, cholangiocarcinoma; with hepatocellular carcinoma, hepatocellular carcinoma stage iiib, hepatocellular carcinoma stage iv